undamentalytics Newsletter
Sign in

Core Scientific, Inc. balance sheet

At the end of fiscal 2025, Core Scientific, Inc. had total assets of $2.35bn, total liabilities of $3.31bn and shareholders' equity of −$963m. It held $311m in cash against $1.08bn of debt: net debt of $774m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents911816508363111,770
Receivables—1011——
Total current assets—75785979048962,444
Goodwill—1,05600———
Total assets02,4398087121,4762,3485,257
Accounts payable—125415519126112
Deferred revenue (current)—6378—18128287
Total current liabilities03201874881357812,738
Short-term debt—————0—
Long-term debt—65206841,0741,0604,298
Total debt0728368081,0901,0854,385
Total liabilities01,0531,2171,3092,4193,3107,677
Shareholders' equity891,341−409−597−943−963−2,419
Non-controlling interests and other (assets − liabilities − equity)−89——————
Net debt (negative = net cash)−9610207582547742,615
Shares outstanding—272m375m387m293m314m320m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CORZ vs FVRRCORZ vs FUFUCORZ vs NBISCORZ vs HUT

More: Internet Services & Infrastructure stocks compared, Technology sector, rankings of US companies

Figures from Core Scientific, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Core Scientific, Inc.